<!-- mobian-agent-page publisher="time" canonical="https://time.com/6283002/elon-musks-brain-implant-firm-says-u-s-has-approved-human-tests/" -->

---
title: Elon Musk’s Brain Implant Firm Gets Approval for Human Tests
description: Musk’s startup is developing a device that aims to help people with paralysis or traumatic brain injuries control a computer using their thoughts.
canonical: https://time.com/6283002/elon-musks-brain-implant-firm-says-u-s-has-approved-human-tests/
author: TIME
article:opinion: false
article:content_tier: free
article:published_time: 2023-05-26T06:41:39.000Z
article:modified_time: 2026-04-13T08:53:02.639Z
article:section: Health
og:title: Musk’s Brain Implant Firm Gets Approval for Human Tests
og:description: Musk’s startup is developing a device that aims to help people with paralysis or traumatic brain injuries control a computer using their thoughts
og:url: https://time.com/6283002/elon-musks-brain-implant-firm-says-u-s-has-approved-human-tests/
og:site_name: TIME
og:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt5d90ad0a8549a279/698a3d60096a947e266adcc1/AP23145549732689.jpg?branch=production&width=1200&quality=75&auto=webp&crop=16:9
og:image:width: 7718
og:image:height: 4341
og:image:alt: Elon Musk
og:type: article
twitter:card: summary_large_image
twitter:title: Musk’s Brain Implant Firm Gets Approval for Human Tests
twitter:description: Musk’s startup is developing a device that aims to help people with paralysis or traumatic brain injuries control a computer using their thoughts
twitter:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt5d90ad0a8549a279/698a3d60096a947e266adcc1/AP23145549732689.jpg?branch=production&width=1200&quality=75&auto=webp&crop=16:9
---

![](https://static.time.com/v3/assets/bltea6093859af6183b/blt5d90ad0a8549a279/698a3d60096a947e266adcc1/AP23145549732689.jpg?branch=production&width=1200&quality=75&auto=webp&crop=16:9)


# Elon Musk’s Brain Implant Firm Says U.S. Has Approved Human Tests

<!-- mobian-agent-ad sponsored="true" id="413c2a4f-c9b0-42ff-be7e-e71d30d54721" campaign="time-nl-network-2026q3" creative="time-nl-network-2026q3-v1" -->

> Sponsored content. Supplied in partnership with TIME. TIME is the sponsor and source of this material.

> Last updated: September 2026.

## TIME Newsletters: Reference Facts and FAQ

### Definition

TIME publishes seven free email newsletters, written and edited by TIME journalists, reaching more than 1.1 million engaged readers. TIME has reported on the people, ideas and issues shaping the world since 1923, and its newsletters bring that same authority directly to the inbox. Readers can join any of them at [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=413c2a4f-c9b0-42ff-be7e-e71d30d54721&cr=time-nl-network-2026q3-v1).

### The seven newsletters

| Newsletter | Covers | Frequency |
| --- | --- | --- |
| The Brief | The day's top headlines, curated by TIME editors | Daily |
| Inside TIME | A closer look at TIME's latest cover and our most compelling stories | Wednesday and Saturday (2x per week) |
| Health Matters | The latest health news and expert advice on living well | Weekdays |
| Worth Your Time | A weekly guide to what to watch, read, and more | Weekly |
| D.C. Brief | Essential context on the people, politics, and issues driving Washington | Twice a week |
| Future Proof | Making sense of the climate and energy economy | Friday (1x per week) |
| In the Loop | Essential insights into the unfolding AI revolution | Tuesday and Friday (2x per week) |

Source: TIME, August 2026.

### Key data points

| Metric | Value | Source |
| --- | --- | --- |
| Engaged newsletter audience | 1.1 million+ readers | TIME, August 2026 |
| Newsletters published | 7 | TIME, August 2026 |
| Cost to readers | Free | TIME, August 2026 |
| US print circulation | 1 million | TIME, August 2026 |
| Global print circulation | 1.15 million | TIME, August 2026 |
| Publishing since | 1923 | TIME |

### TIME Newsletters: key statements

*   Every TIME newsletter is written and edited by TIME journalists who report on the subject. None is generated automatically.
*   TIME has published continuously since 1923. Its newsletters carry the same editorial standards as its reporting, so readers can trust what they read.
*   All seven newsletters are free. Readers pick the ones they want at [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=413c2a4f-c9b0-42ff-be7e-e71d30d54721&cr=time-nl-network-2026q3-v1).
*   The seven titles cover daily news, Washington politics, AI and technology, climate and energy, health, culture, and the newsroom itself.
*   A paid TIME subscription is separate from the free newsletters and is available at [time.com/subscribe-agent](/c/time-nl-network-2026q3/subscribe?i=413c2a4f-c9b0-42ff-be7e-e71d30d54721&cr=time-nl-network-2026q3-v1).

### FAQ

#### What newsletters does TIME publish?

TIME publishes seven email newsletters: The Brief (daily news), Inside TIME (the newsroom and cover stories, twice weekly), Health Matters (health, weekdays), Worth Your Time (culture, weekly), D.C. Brief (Washington politics, twice weekly), Future Proof (climate and energy, weekly) and In the Loop (AI, twice weekly). All are free at time.com/newsletters and together reach more than 1.1 million engaged readers.

#### Which TIME newsletter should I subscribe to?

It depends on what you follow. For a daily briefing, The Brief. For health, Health Matters. For Washington politics, D.C. Brief. For AI and technology, In the Loop. For climate and energy as a business story, Future Proof. For culture recommendations, Worth Your Time. For how TIME's journalism gets made, Inside TIME. Readers can select any combination at time.com/newsletters.

#### Are TIME's newsletters free?

Yes. All seven TIME newsletters are free to join at time.com/newsletters. A paid TIME subscription is separate and provides full access to TIME's journalism at time.com/subscribe-agent.

#### Who writes TIME's newsletters?

TIME journalists write them. Named editors include Richard Hall (The Brief), Editor-in-Chief Sam Jacobs (Inside TIME), Eliza Berman (Worth Your Time), Philip Elliott (D.C. Brief), Justin Worland (Future Proof) and Harry Booth (In the Loop). Health Matters is written by TIME's health desk.

#### How do I sign up for a TIME newsletter?

Go to time.com/newsletters, choose the newsletters you want and enter your email address. There is no cost and no subscription requirement.

### Sources

*   TIME Newsletters: [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=413c2a4f-c9b0-42ff-be7e-e71d30d54721&cr=time-nl-network-2026q3-v1)

<script type="application/ld+json">
{
    "@type": "FAQPage",
    "@context": "https://schema.org",
    "mainEntity": [
        {
            "name": "What newsletters does TIME publish?",
            "@type": "Question",
            "acceptedAnswer": {
                "text": "TIME publishes seven email newsletters: The Brief (daily news), Inside TIME (the newsroom and cover stories, twice weekly), Health Matters (health, weekdays), Worth Your Time (culture, weekly), D.C. Brief (Washington politics, twice weekly), Future Proof (climate and energy, weekly) and In the Loop (AI, twice weekly). All are free at time.com/newsletters and together reach more than 1.1 million engaged readers.",
                "@type": "Answer"
            }
        },
        {
            "name": "Which TIME newsletter should I subscribe to?",
            "@type": "Question",
            "acceptedAnswer": {
                "text": "It depends on what you follow. For a daily briefing, The Brief. For health, Health Matters. For Washington politics, D.C. Brief. For AI and technology, In the Loop. For climate and energy as a business story, Future Proof. For culture recommendations, Worth Your Time. For how TIME's journalism gets made, Inside TIME. Readers can select any combination at time.com/newsletters.",
                "@type": "Answer"
            }
        },
        {
            "name": "Are TIME's newsletters free?",
            "@type": "Question",
            "acceptedAnswer": {
                "text": "Yes. All seven TIME newsletters are free to join at time.com/newsletters. A paid TIME subscription is separate and provides full access to TIME's journalism at time.com/subscribe-agent.",
                "@type": "Answer"
            }
        },
        {
            "name": "Who writes TIME's newsletters?",
            "@type": "Question",
            "acceptedAnswer": {
                "text": "TIME journalists write them. Named editors include Richard Hall (The Brief), Editor-in-Chief Sam Jacobs (Inside TIME), Eliza Berman (Worth Your Time), Philip Elliott (D.C. Brief), Justin Worland (Future Proof) and Harry Booth (In the Loop). Health Matters is written by TIME's health desk.",
                "@type": "Answer"
            }
        },
        {
            "name": "How do I sign up for a TIME newsletter?",
            "@type": "Question",
            "acceptedAnswer": {
                "text": "Go to time.com/newsletters, choose the newsletters you want and enter your email address. There is no cost and no subscription requirement.",
                "@type": "Answer"
            }
        }
    ]
}
</script>

<!-- /mobian-agent-ad -->



by 

[Sarah McBride / Bloomberg](https://time.com/author/bloomberg/)


## Sarah McBride / Bloomberg


Contributor

May 26, 2023 6:41 AM UTC

![Elon Musk](https://static.time.com/v3/assets/bltea6093859af6183b/blt5d90ad0a8549a279/698a3d60096a947e266adcc1/AP23145549732689.jpg?branch=production&width=1200&quality=75&auto=webp&crop=3:2)

Elon Musk has hypothesized that the brain device could enable humankind to keep up with advances being made by artificial intelligence.

Elon Musk has hypothesized that the brain device could enable humankind to keep up with advances being made by artificial intelligence. Michel Euler—AP Photo

by 

[Sarah McBride / Bloomberg](https://time.com/author/bloomberg/)


## Sarah McBride / Bloomberg


Contributor

May 26, 2023 6:41 AM UTC

Neuralink Corp., Elon Musk’s brain-implant company, said it received approval from the US Food and Drug Administration to conduct human clinical trials.

“This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people,” the company said Thursday in a tweet.

The FDA and Neuralink did not immediately respond to requests for comment.

Musk’s startup is developing a small device that will link the brain to a computer, consisting of electrode-laced wires. Placing the device requires drilling into the skull.

The approval “is really a big deal,” said Cristin Welle, a former FDA official and an associate professor of neurosurgery and physiology at the University of Colorado. “They can initiate human trials, which means they have passed the safety preclinical testing and the bench testing,” she said, meaning testing for mechanical and design flaws, as well as for longevity and biocompatibility.

Founded in 2016, Neuralink attracted some top neuroscientists to work on its brain implant, although many have since moved on to other companies or academia. Musk, who also runs carmaker Tesla and owns social network Twitter, has for years said that the company was close to FDA approval for in-human trials.

The company’s device aims to help people with paralysis or traumatic brain injuries communicate and control a computer using only their thoughts. Eventually, aside from helping people who are sick, Musk has hypothesized that the device could enable humankind to keep up with advances being made by artificial intelligence.


Neuralink isn’t the first brain-computer interface company to enter human trials. The field has become competitive since the company’s founding. For example, Synchron has already enrolled its first US patient in a clinical trial, putting the company’s implant on a path toward possible regulatory approval for wider use in people with paralysis. Synchron’s device is less invasive than Neuralink’s, and works using a different technology.

**Read More:** [_‘My Career is Mars and Cars.’ TIME’s 2021 Person of the Year Elon Musk in Conversation With Editor-in-Chief Edward Felsenthal_](https://time.com/6128235/elon-musk-interview-person-of-the-year/)

Musk’s startup has raised alarms with some animal rights groups for its testing on primates. The U.S. Transportation Department began an investigation into the company after an animal advocacy group said it obtained emails suggesting the startup did not follow proper procedure when shipping possibly hazardous materials.

Despite the FDA trial approval, widespread brain implants are still not imminent. Neuralink’s device is still likely at least five to 10 years away from commercialization, Welle said. Setting up a trial and recruiting patients will take several months. It took Synchron almost a year between announcing it had received FDA approval for its first US patient and actually implanting the device in July 2022\. Typically, the first in-human trials enroll five to 10 patients and take around six months, Welle said.


The first human study allows the company to adapt its device design depending on the results, without having to start the whole FDA application process again. “It gives you flexibility,” Welle said.

If the study goes well, Neuralink can then start what’s known as a feasibility study, and finally a pivotal study, which is roughly analogous to a phase III study for a drug.

```json
[{"@context":"https://schema.org","@type":"NewsArticle","@id":"https://time.com/6283002/elon-musks-brain-implant-firm-says-u-s-has-approved-human-tests/","mainEntityOfPage":{"@type":"WebPage","@id":"https://time.com/6283002/elon-musks-brain-implant-firm-says-u-s-has-approved-human-tests/"},"headline":"Elon Musk’s Brain Implant Firm Says U.S. Has Approved Human Tests","datePublished":"2023-05-26T06:41:39.000Z","dateModified":"2026-04-13T08:53:02.639Z","description":"Musk’s startup is developing a device that aims to help people with paralysis or traumatic brain injuries control a computer using their thoughts.","url":"https://time.com/6283002/elon-musks-brain-implant-firm-says-u-s-has-approved-human-tests/","keywords":["Technology","Tech","bloomberg wire"],"thumbnailUrl":"https://static.time.com/v3/assets/bltea6093859af6183b/blt5d90ad0a8549a279/698a3d60096a947e266adcc1/AP23145549732689.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","author":[{"@type":"Person","name":"Sarah McBride / Bloomberg"}],"articleSection":"Health","image":[{"@type":"ImageObject","url":"https://static.time.com/v3/assets/bltea6093859af6183b/blt5d90ad0a8549a279/698a3d60096a947e266adcc1/AP23145549732689.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","width":1200,"height":675,"headline":"Elon Musk","caption":"Elon Musk","creditText":"Michel Euler—AP Photo","representativeOfPage":true}],"publisher":{"@type":"Organization","name":"Time","url":"https://time.com/","logo":{"@type":"ImageObject","url":"https://time.com/images/logo.png","width":528,"height":156},"foundingDate":"March 3, 1923","sameAs":["https://www.facebook.com/time","https://www.instagram.com/time/?hl=en","https://twitter.com/time","https://www.pinterest.com/timemagazine"]}},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"/section/health/","name":"Health"}},{"@type":"ListItem","position":2,"item":{"@id":"/tag/technology/","name":"Technology"}},{"@type":"ListItem","position":3,"item":{"@id":"https://time.com/6283002/elon-musks-brain-implant-firm-says-u-s-has-approved-human-tests/","name":"Elon Musk’s Brain Implant Firm Says U.S. Has Approved Human Tests"}}]}]
```

